Cost of Anti-retroviral Medicines in Indonesia

 

ARVs

Price of patented ARV before 2000 (per 60 tablets) (US$)

Price of patented ARV after 2000 (per 60 tablets) (US$)

Price of generic ARV after government-use authorization (per 60 tablets) (US$)

Lamivudine + zidovudine + nevirapine

800-1,000

600

18-65*

Lamivudine (3TC)

NA

290-330**

28

Nevirapine (Viramune)

NA

96

28

Lamivudine + zidovudine (Combivir)

NA

400

48.60

*The range of subsidized and full-cost prices that patients have to pay.
**The price range in different pharmacies. Indonesia does not have price control on medicines and therefore pharmacies and hospitals charge different prices
Note: The brands of the patented ARVs are in brackets.

Source: Lutifyah and Hira (2006). Data obtained through interview with PT Kimia Farma, the Indonesian generic manufacturer. Cited in M Khor, “Patents, Compulsory Licenses and Access to Medicines: Some Recent Experiences,” Third World Network, 2009.

Kaletra or Aluvia (lopinavr+ritonavir marketed by Abbott Laboratories) costs $83.3 per patient per month, over $1,000 per patient per year for public programs. The private sector price is several times more. (Abbott Laboratories, November 2011)

 

Back to HIV/AIDS Treatment in Indonesia               Next to Funding for HIV/AIDS Initiatives

Back to Indonesia Action page